Dexamethasone palmitate-d₃₁

Cat. No.: HY-128922S: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Dexamethasone palmitate-d31 is the deuterium labeled Dexamethasone palmitate(HY-128922).Dexamethasone palmitate (DXP) is a proagent of Dexamethasone (HY-14648). Dexamethasone palmitate can be used for the research of inflammation.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Dexamethasone palmitate-d₃₁ 화학구조

사이즈	가격	재고	수량
1 mg		견적 받기	Estimated Time of Arrival: December 31
2.5 mg		해외재고보유	Estimated Time of Arrival: December 31

or 대량구매 문의

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

Other Forms of Dexamethasone palmitate-d₃₁:

Dexamethasone palmitate In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Sodium Channel Isoform Specific Products:

View All Isoforms

Na_v1.1 Na_v1.2 Na_v1.3 Na_v1.4 Na_v1.5 Na_v1.6 Na_v1.7 Na_v1.8 Na_v1.9

Biological Activity
순도&문서
References
고객리뷰

제품 설명

Application

1. This compound can be used as a tracer.
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

분자량

662.06

화학식

C₃₈H₂₈D₃₁FO₆

Unlabeled CAS

14899-36-6

Appearance

Solid

Color

Colorless to off-white

SMILES

C[C@@]12[C@](C[C@@H](C)[C@@]2(C(COC(C([2H])([2H])C([2H])(C([2H])([2H])C([2H])(C([2H])([2H])C([2H])(C([2H])([2H])C([2H])([2H])C([2H])(C([2H])([2H])C([2H])([2H])C([2H])(C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])[2H])[2H])[2H])[2H])[2H])=O)=O)O)([H])[C@@]3([H])[C@@](F)([C@@]4(C(CC3)=CC(C=C4)=O)C)[C@@H](O)C1

선적

Room temperature in continental US; may vary elsewhere.

보관

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

순도&문서

Purity: 99.31%

Select Batch:

Data Sheet (268 KB) SDS (251 KB)

COA (251 KB)

Handling Instructions (2659 KB)

References

[1]. Daull P, et al. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J Ocul Pharmacol Ther. 2013 Mar;29(2):258-69. [Content Brief]

[2]. Lorscheider M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release. 2019 Feb 28;296:179-189. [Content Brief]

[3]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]